We are live on ! Find out more
AWH

Aspira Women's Health Inc. Common Stock

Delisted

AWH was delisted on the 16th of April, 2025.

92 hedge funds and large institutions have $22.9M invested in Aspira Women's Health Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 36 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 9892 (-6)

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

36% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 36

55% less capital invested

Capital invested by funds: $50.8M → $22.9M (-$28M)

Holders
92
Holders Change
-6
Holders Change %
-6.12%
% of All Funds
1.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
23
Reduced
36
Closed
18
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
51
Tower Research Capital (TRC)
New York
$38K -$7.31K -422 -15%
AIG
52
American International Group
New York
$38K -$2.95K -170 -7%
BTWM
53
Baker Tilly Wealth Management
Wisconsin
$38K +$17.6K +1,016 +70%
Janney Montgomery Scott
54
Janney Montgomery Scott
Pennsylvania
$32K +$15.8K +913 +82%
State Board of Administration of Florida Retirement System
55
State Board of Administration of Florida Retirement System
Florida
$31K
Invesco
56
Invesco
Georgia
$29K -$641 -37 -2%
VOYA Investment Management
57
VOYA Investment Management
Georgia
$28K
Wells Fargo
58
Wells Fargo
California
$27K -$29.3K -1,689 -49%
Bank of America
59
Bank of America
North Carolina
$26K -$140K -8,107 -83%
HighTower Advisors
60
HighTower Advisors
Illinois
$21K -$763 -44 -3%
Fidelity Investments
61
Fidelity Investments
Massachusetts
$21K +$23K +1,325 New
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$20.7K -$15.1K -871 -40%
GAM
63
Griffin Asset Management
New York
$19K -$2.31K -133 -10%
Ameriprise
64
Ameriprise
Minnesota
$17K +$18.9K +1,092 New
OA
65
Operose Advisors
Wisconsin
$16K
Wolverine Trading
66
Wolverine Trading
Illinois
$16K +$18.1K +1,046 New
BCI
67
Brinker Capital Investments
Pennsylvania
$16K +$18.3K +1,055 New
Principal Financial Group
68
Principal Financial Group
Iowa
$15K +$2.18K +126 +15%
APA
69
American Portfolios Advisors
New York
$14.1K +$1.84K +106 +13%
ProShare Advisors
70
ProShare Advisors
Maryland
$14K -$2.6K -150 -14%
ASRS
71
Arizona State Retirement System
Arizona
$14K +$69 +4 +0.4%
Barclays
72
Barclays
United Kingdom
$13K +$14.2K +822 New
Envestnet Asset Management
73
Envestnet Asset Management
Illinois
$12K -$2.55K -147 -16%
AB
74
Amalgamated Bank
New York
$12K -$1.16K -67 -8%
AF
75
Amalgamated Financial
New York
$12K +$13.7K +789 New

AWH Hedge Fund Activity: Q1 2022 in Review

92 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Aspira Women's Health Inc. Common Stock (AWH) for Q1 2022, worth a combined $22.9M — down 55% from $50.8M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of AWH and 12 opened new positions — a net loss of 6 holders — while 36 trimmed existing stakes and 23 added.

The largest buyer was B. Riley Wealth Management, adding an estimated $284K. The largest seller was Oracle Investment Management, cutting an estimated $3.96M.

  • 92 institutional investors held Aspira Women's Health Inc. Common Stock (AWH) as of Q1 2022, down from 98 in Q4 2021.
  • Funds reported $22.9M of Aspira Women's Health Inc. Common Stock stock for Q1 2022, down 55% quarter-over-quarter.
  • 12 funds opened new Aspira Women's Health Inc. Common Stock positions in Q1 2022 and 18 closed out, a net change of -6 holders.
  • The largest Aspira Women's Health Inc. Common Stock buyer in Q1 2022 was B. Riley Wealth Management, an estimated $284K added.
  • The largest Aspira Women's Health Inc. Common Stock seller in Q1 2022 was Oracle Investment Management, an estimated $3.96M sold.

Based on aggregated 13F filings for Q1 2022.